Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedAug 15, 2026
DataAggregated Company Financials
Companies20
  • 7D-2.3%
  • 3M1.3%
  • 1Y-7.2%
  • YTD-9.5%

Over the last 7 days, the Healthcare industry has risen 2.1%, driven by gains from Genmab of 7.9%. In contrast, the industry has lost 5.8% in the last 12 months. As for the next few years, earnings are expected to grow by 4.2% per annum.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 15 Aug 2026DKK 1.8tDKK 469.1bDKK 137.8b23.1x12.8x3.7x
Mon, 13 Jul 2026DKK 1.9tDKK 469.2bDKK 147.1b20.6x12.6x4x
Wed, 10 Jun 2026DKK 1.6tDKK 468.9bDKK 147.1b19.8x11x3.4x
Fri, 08 May 2026DKK 1.7tDKK 466.4bDKK 149.5b20.7x11.5x3.7x
Sun, 05 Apr 2026DKK 1.5tDKK 447.8bDKK 130.1b17.4x11.3x3.3x
Tue, 03 Mar 2026DKK 1.5tDKK 447.7bDKK 130.9b18.7x11.5x3.3x
Thu, 29 Jan 2026DKK 2.2tDKK 453.2bDKK 136.7b17.7x15.9x4.8x
Sat, 27 Dec 2025DKK 2.0tDKK 453.7bDKK 136.8b17.1x14.4x4.3x
Mon, 24 Nov 2025DKK 1.9tDKK 454.3bDKK 137.1b17.1x13.5x4.1x
Wed, 22 Oct 2025DKK 2.1tDKK 447.6bDKK 141.8b19.2x14.9x4.7x
Fri, 19 Sep 2025DKK 2.2tDKK 447.2bDKK 141.6b19.1x15.8x5x
Sun, 17 Aug 2025DKK 1.9tDKK 444.4bDKK 140.2b28.1x13.6x4.3x
Tue, 15 Jul 2025DKK 2.4tDKK 423.2bDKK 124.5b29.9x19.4x5.7x
Thu, 12 Jun 2025DKK 2.8tDKK 423.6bDKK 124.6b31.3x22.3x6.6x
Sat, 10 May 2025DKK 2.4tDKK 423.4bDKK 124.9b22.6x19.4x5.7x
Mon, 07 Apr 2025DKK 2.4tDKK 409.5bDKK 121.3b22.8x19.4x5.8x
Wed, 05 Mar 2025DKK 3.3tDKK 410.0bDKK 121.4b26.9x26.8x7.9x
Fri, 31 Jan 2025DKK 3.3tDKK 387.4bDKK 111.3b28.6x29.2x8.4x
Sun, 29 Dec 2024DKK 3.4tDKK 387.4bDKK 111.3b29.9x30.1x8.7x
Tue, 26 Nov 2024DKK 3.9tDKK 387.4bDKK 111.3b31.2x34.7x10x
Thu, 24 Oct 2024DKK 4.1tDKK 372.2bDKK 107.2b34.2x38.4x11.1x
Sat, 21 Sep 2024DKK 4.4tDKK 371.9bDKK 107.1b37.4x40.8x11.8x
Mon, 19 Aug 2024DKK 4.7tDKK 370.7bDKK 107.0b37.2x43.9x12.7x
Wed, 17 Jul 2024DKK 4.9tDKK 355.2bDKK 106.2b35.2x46.1x13.8x
Fri, 14 Jun 2024DKK 5.0tDKK 355.3bDKK 106.2b36.4x46.6x13.9x
Sun, 12 May 2024DKK 4.5tDKK 354.9bDKK 106.0b34.6x42.5x12.7x
Tue, 09 Apr 2024DKK 4.5tDKK 341.2bDKK 99.6b37.4x44.9x13.1x
Thu, 07 Mar 2024DKK 4.4tDKK 340.0bDKK 98.9b38.2x44.3x12.9x
Sat, 03 Feb 2024DKK 4.0tDKK 338.6bDKK 98.5b32.7x40.6x11.8x
Mon, 01 Jan 2024DKK 3.6tDKK 320.4bDKK 90.0b32.8x40.4x11.3x
Wed, 29 Nov 2023DKK 3.6tDKK 320.4bDKK 90.0b33x39.7x11.2x
Fri, 27 Oct 2023DKK 3.5tDKK 305.7bDKK 82.3b26.7x42.5x11.4x
Sun, 24 Sep 2023DKK 3.4tDKK 305.5bDKK 82.2b33.8x41.3x11.1x
Tue, 22 Aug 2023DKK 3.3tDKK 303.6bDKK 81.3b36.3x40.8x10.9x
Price to Earnings Ratio

40.8x


Total Market Cap: DKK 3.3tTotal Earnings: DKK 81.3bTotal Revenue: DKK 303.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 28.2x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 12.5x which is lower than its 3-year average PE of 28.2x.
  • The 3-year average PS ratio of 8.2x is higher than the industry's current PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 20% per year over the last three years.
  • Revenues for these companies have grown 16% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market1.48%
Healthcare-2.31%
Healthcare Services6.79%
Life Sciences5.41%
Medical Equipment1.15%
Biotech1.11%
Healthtech-0.50%
Pharma-3.22%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 32.8x.
    • Analysts are expecting annual earnings growth of 21.0%, which is higher than its past year's earnings growth of 9.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 113% over the next 5 years.
  • In contrast, the Life Sciences industry is expected to see its earnings decline by 8.2% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DEMANT DemantDKK 297.405.4%
+DKK 3.2b		20.6%PE25.9x
GMAB GenmabDKK 2.03k1.4%
+DKK 1.7b		35.4%PE23.8x
HLUN B H. LundbeckDKK 42.522.3%
+DKK 931.8m		8.9%PE11.3x
AMBU B AmbuDKK 76.554.3%
+DKK 831.1m		-16.7%PE42.3x
BAVA Bavarian NordicDKK 185.905.4%
+DKK 725.3m		-21.7%PE12.1x

Latest News

ALK B
DKK 218.60
ALK-Abelló
7D
-2.4%
1Y
19.5%
ZEAL
DKK 321.20
Zealand Pharma
7D
-3.0%
1Y
-13.4%
PEG
DKK 0.082
Pharma Equity Group
7D
-10.1%
1Y
-40.9%
BAVA
DKK 185.90
Bavarian Nordic
7D
5.4%
1Y
-21.7%
DEMANT
DKK 297.40
Demant
7D
5.4%
1Y
20.6%
CHEMM
DKK 463.20
ChemoMetec
7D
7.7%
1Y
-7.5%
NOVO B
DKK 294.70
Novo Nordisk
7D
-3.4%
1Y
-9.6%
Narrative Update • Aug 10

NOVO: From Hypergrowth to Execution Mode

10.08.2026 New CEO Mike Doustdar: His strength lies less in building factories and more in building markets. From my perspective, the share price has been driven by a lot of exaggeration.
GMAB
DKK 2,027.00
Genmab
7D
1.4%
1Y
35.4%
Analysis Article • Aug 09

Genmab A/S Just Beat EPS By 29%: Here's What Analysts Think Will Happen Next

It's been a good week for Genmab A/S ( CPH:GMAB ) shareholders, because the company has just released its latest...
GUBRA
DKK 371.80
Gubra
7D
2.5%
1Y
5.3%
HLUN B
DKK 42.52
H. Lundbeck
7D
2.3%
1Y
8.9%
EMBLA
DKK 29.85
Embla Medical hf
7D
1.7%
1Y
-3.1%
Analysis Article • Jul 24

Embla Medical hf. Just Recorded A 28% EPS Beat: Here's What Analysts Are Forecasting Next

Embla Medical hf. ( CPH:EMBLA ) last week reported its latest second-quarter results, which makes it a good time for...
AMBU B
DKK 76.55
Ambu
7D
4.3%
1Y
-16.7%
Narrative Update • Jul 15

AMBU B: Margin Resilience And Competitive Response Are Expected To Drive Future Upside

The analyst price target for Ambu has been cut from DKK 138.0 to DKK 116.4, as analysts adopt more cautious assumptions around competition, growth, margins, discount rate and future P/E following recent bearish research updates. Analyst Commentary Recent research on Ambu has leaned more cautious, with some price targets and ratings adjusted to reflect concerns about competition and the near term outlook.
COLO B
DKK 428.30
Coloplast
7D
-2.1%
1Y
-29.0%
Narrative Update • Jul 15

COLO B: Recent P/E Reset Will Create Upside Opportunity

Analysts have lowered the fair value estimate for Coloplast to DKK 584 from DKK 868, reflecting a reset in price assumptions and P/E expectations, while recent price targets across the Street range from DKK 345 to DKK 484. Analyst Commentary Recent Street research on Coloplast shows a wide spread in views, but there are several constructive signals that point to ongoing interest in the stock at current levels.
MONSO
DKK 0.24
Monsenso
7D
-13.7%
1Y
5.3%
NNIT
DKK 38.25
NNIT
7D
-0.1%
1Y
-39.1%
STENO
DKK 0.93
Stenocare
7D
-0.2%
1Y
34.8%